who medicines strategy - libdoc.who.int - World Health Organization
who medicines strategy - libdoc.who.int - World Health Organization who medicines strategy - libdoc.who.int - World Health Organization
WHO MEDICINES STRATEGY 2004-2007 | 138Figure 30: Creation, synthesis, and dissemination of knowledgeStimulating strategic and operational researchCreate knew knowledge, through networking and collaboration, to meet presentand future challenges relating to pharmaceuticals; and identify innovative andviable approaches to ensure access to, and the quality and appropriate use ofmedicines.Articulating and advocating policy optionsDevelop and disseminate needs-driven, ethical, evidence-based and actionorientedpolicy options to help countries — confronted with many difficultdecisions in a changing global context — manage their pharmaceutical sector andincrease its contribution to public health.Developing norms and standardsDevelop norms and standards as a foundation for the effective regulation, control,manufacture, and sale of medicines, and to guide international harmonization ofthe pharmaceutical trade.Producing guidelines and practical toolsProvide policy-makers and essential medicines managers with practical guidelinesand tools for implementing the components of a national medicine policy andfor promoting capacity-building, particularly when there is a lack of nationalpharmaceutical experts.Developing human resourcesBuild country capacity to effectively implement the various components of anational medicine policy by developing clear guidelines on the human resourcesrequired, ensuring that undergraduate and postgraduate curricula for all healthprofessions incorporate the essential medicines concept, and developing andpromoting in-service training and supervision for health staff at all levels.Managing informationSynthesize and disseminate information on pharmaceutical issues, includingassessing trends, comparing performance, and monitoring the potential impacts onhealth of global economic, social or political developments.
MONITORINGPROGRESS
- Page 100 and 101: WHO MEDICINES STRATEGY 2004-2007 |
- Page 102 and 103: WHO MEDICINES STRATEGY 2004-2007 |
- Page 104 and 105: WHO MEDICINES STRATEGY 2004-2007 |
- Page 106 and 107: WHO MEDICINES STRATEGY 2004-2007 |
- Page 108 and 109: WHO MEDICINES STRATEGY 2004-2007 |
- Page 110 and 111: WHO MEDICINES STRATEGY 2004-2007 |
- Page 112 and 113: WHO MEDICINES STRATEGY 2004-2007 |
- Page 114 and 115: WHO MEDICINES STRATEGY 2004-2007 |
- Page 116 and 117: WHO MEDICINES STRATEGY 2004-2007 |
- Page 118 and 119: WHO MEDICINES STRATEGY 2004-2007 |
- Page 120 and 121: WHO MEDICINES STRATEGY 2004-2007 |
- Page 122 and 123: WHO MEDICINES STRATEGY 2004-2007 |
- Page 124 and 125: WHO MEDICINES STRATEGY 2004-2007 |
- Page 126 and 127: WHO MEDICINES STRATEGY 2004-2007 |
- Page 128 and 129: WHO MEDICINES STRATEGY 2004-2007 |
- Page 130 and 131: WHO MEDICINES STRATEGY 2004-2007 |
- Page 132 and 133: WHO MEDICINES STRATEGY 2004-2007 |
- Page 134 and 135: WHO MEDICINES STRATEGY 2004-2007 |
- Page 136 and 137: WHO MEDICINES STRATEGY 2004-2007 |
- Page 138 and 139: WHO MEDICINES STRATEGY 2004-2007 |
- Page 140 and 141: WHO MEDICINES STRATEGY 2004-2007 |
- Page 142 and 143: WHO MEDICINES STRATEGY 2004-2007 |
- Page 144 and 145: WHO MEDICINES STRATEGY 2004-2007 |
- Page 146 and 147: WHO MEDICINES STRATEGY 2004-2007 |
- Page 148 and 149: WHO MEDICINES STRATEGY 2004-2007 |
- Page 152 and 153: WHO MEDICINES STRATEGY 2004-2007 |
- Page 154 and 155: WHO MEDICINES STRATEGY 2004-2007 |
- Page 157 and 158: REFERENCES
- Page 159 and 160: REFERENCES | 1471Annual report 2000
- Page 161 and 162: REFERENCES | 14912 th Model List of
MONITORINGPROGRESS
Change language